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Adrenomedullin, a potent vasoactive peptide, is
actively secreted from primary cultures of human
oral and skin keratinocytes, but nothing is known of
the regulation of its release. This study describes the
effects of a range of substances on adrenomedullin
production from cultures of oral and skin keratino-
cytes. We have established that keratinocytes do not
store adrenomedullin but secrete it constitutively.
Cytokines interleukin-1a and -1b, tumor necrosis
factor-a and -b, and the bacterial product, lipopoly-
saccharide, signi®cantly stimulate adrenomedullin
secretion from oral but not skin keratinocytes. Both
transforming growth factor-b1 and interferon-g are
potent suppressors of adrenomedullin secretion from
both cell types, as are forskolin, di-butyryl cyclic
adenosine monophosphate, and adrenocorticotropin.
The peptides thrombin and endothelin-1 increase
adrenomedullin production, particularly from skin
keratinocytes. These ®ndings indicate that there are
differences in the regulation of adrenomedullin pro-
duction between oral and skin keratinocytes and that
oral keratinocytes are particularly responsive to the
action of in¯ammatory cytokines. This raises the
possibility that adrenomedullin may serve a different
functions in oral mucosa and skin. Key words: cyto-
kines/peptide regulation/peptides secretion/primary cell
culture. J Invest Dermatol 117:353±359, 2001
K
eratinocytes form the epithelial barrier in oral mucosa
and skin and as well as maintaining structural integrity
play an active part in local immune defense. They
synthesize and release in¯ammatory cytokines, and
chemokines such as interleukin (IL) -1, IL-6, tumor
necrosis factor (TNF) -a, IL-12, IL-8, and RANTES in response
to a variety of environmental stimuli, including the bacterial
product, lipopolysaccharide (LPS), ultraviolet light, and other
in¯ammatory cytokines (reviewed in Kondo, 1999). Production of
these cytokines modulates the activities of other keratinocytes,
®broblasts, endothelial cells, and leukocytes, and is important in the
generation of local immune and in¯ammatory responses.
In addition to in¯ammatory cytokines, keratinocytes produce a
variety of growth factors and peptides. One of these is
adrenomedullin (AM), a potent vasoactive peptide ®rst extracted
from a human pheochromocytoma (Kitamura et al, 1993a). Human
AM is a 52 amino acid peptide with a single disul®de bridge
between residues 16 and 21 and with an amidated tyrosine at the
carboxy terminus (Kitamura et al, 1993b). It shows modest
structural homology with calcitonin gene-related peptide and is a
member of the calcitonin gene-related peptide/amylin peptide
family. The AM gene is expressed in a wide range of tissues
(reviewed in Hinson et al, 2000 and references therein). An initial
report on the distribution of AM mRNA suggested that the highest
levels of expression were seen in the adrenal medulla, ventricle,
kidney, and lung. Since the discovery that the AM gene is even
more highly expressed in endothelial cells than in the adrenal
medulla, this peptide together with nitric oxide and endothelin
(ET), have come to be regarded as secretory products of the
vascular endothelium (Hinson et al, 2000).
Speci®c AM receptors have been identi®ed in a variety of
studies, using radioligand-binding techniques, and these receptors
are coupled to adenylyl cyclase, thus elevating cAMP levels when
activated (Eguchi et al, 1994; Ishizaka et al, 1994). Speci®c
receptors for AM are also present on oral and skin keratinocytes
(Kapas et al, 1997; MartõÂnez et al, 1997) and there is evidence these
are functional: AM stimulates keratinocyte proliferation and this
effect may be mimicked by cAMP (Kapas et al, 1997).
Although it has been established that skin keratinocytes
synthesize AM (MartõÂnez et al, 1997) it is not known whether it
is also produced by oral keratinocytes. In addition nothing is
known of the factors that in¯uence its production and hence of its
physiologic role in the skin and oral mucosa. The aims of this study
were to determine whether oral keratinocytes produce AM and to
establish the factors important in modulating its release from oral
and skin keratinocytes.
MATERIALS AND METHODS
Materials Dexamethasone, aldosterone, hydrocortisone, testosterone,
progesterone, estradiol, LPS, bovine thrombin, forskolin, di-butyryl
cAMP, and 12-O-tetradecanoylphorbol13-acetate (TPA) were purchased
from Sigma-Aldrich (Poole, U.K.). Human recombinant IL-1a, IL-1b,
TNF-a, TNF-b, transforming growth factor (TGF)-b1, and interferon
(IFN)-g were purchased from R&D Systems (Abingdon, U.K.). ET-1
and adrenocorticotropin (ACTH) (Synacthen) were obtained from
Bachem (Saffron Walden, U.K.) and Ciba-Geigy (Horsham, Sussex,
Manuscript received June 16, 2000; revised March 30, 2001; accepted
for publication April 2, 2001.
Reprint requests to: Dr. S. Kapas, Molecular Signalling Group, Clinical
Sciences Research Center, Barts & the London, Queen Mary's School of
Medicine & Dentistry, 2 Newark Street, London E1 2AD, U.K.
Email: s.kapas@mds.qmw.ac.uk
Abbreviations: ACTH, adrenocorticopin; AM, adrenomedullin; ET,
endothelin-1.
0022-202X/01/$15.00 ´ Copyright # 2001 by The Society for Investigative Dermatology, Inc.
353
U.K.), respectively. Tissue culture media, reagents, and plastics were
obtained from Life Technologies (Paisley, Scotland). AM enzyme
immunoassay kits and human AM(1±52) peptide were purchased from
Phoenix Pharmaceuticals (Belmont, CA).
Cell culture Primary human oral and skin keratinocytes were derived
from biopsy material that was determined to be normal by histologic
methods as described in detail elsewhere (Rheinwald and Green, 1975).
Cells were grown in 75 cm2 tissue culture ¯asks on a feeder layer of g-
irradiated Swiss 3T3 ®broblasts as described elsewhere (Malcovati and
Tenchini, 1991; Li et al, 2000). Cells were maintained in keratinocyte
growth medium supplemented with 10% fetal bovine serum and
antibiotics in an humidi®ed atmosphere containing 5% CO2 and 95% air
at 37°C as described previously (Kapas et al, 1998a). Twenty-four hours
prior to an experiment cells (from passages 3 to 5) were detached from
the ¯asks and seeded on to 24-well plates or in 75 cm2 tissue culture
¯asks and maintained, without a feeder layer, in serum-free keratinocyte
growth medium.
Measurement of AM Human keratinocytes, grown to 80% con¯uence
in 24-well tissue culture plates, were washed twice in sterile phosphate-
buffered saline and incubated in serum-free keratinocyte growth medium
in the absence and presence of various agents for different lengths of
time. After the incubation period, conditioned medium was harvested,
centrifuged and the supernatant stored at ±20°C until assayed. The cells
were washed in sterile phosphate-buffered saline, scraped in 1 M acetic
acid, sonicated, and centrifuged, and the resulting supernatants were
subjected to enzyme immunoassay tests for AM following the
manufacturer's instructions (Phoenix Pharmaceuticals). The lower
detection limit of the assay was 12 fmol AM per assay; interassay and
intra-assay coef®cients of variance were 14 and 8%, respectively, at
40 fmol AM per tube (n = 20).
RNA analysis Total cellular RNA, reverse transcription, and
polymerase chain reaction (PCR) was performed as described previously
(Kapas et al, 1998a). The sequences of the oligonucleotide primers were
as follows: AM sense: 5¢-atgaagctggtttccgtc-3¢ and anti-sense 5¢-
tgtggcttagaagacacc-3¢, and GAPDH sense: 5¢-ccacagtccatgccatcac-3¢ and
anti-sense: 5¢-tccaccaccctgttgctgta-3¢. PCR products were
electrophoresed through 1% agarose gels and viewed by ultraviolet
illumination and photographed. The PCR bands underwent scanning
densitometry and the relative ratio of the net intensities of the AM and
GAPDH bands from the same PCR reaction was determined to show
AM mRNA expression in response to exposure to various agents.
All experiments were carried in duplicate on four separate occasions
and bar graphs represent the results obtained by pooling data together.
The reverse transcription±PCR data are representative of each experi-
ment.
Statistical analysis Arithmetic means and standard error of the means
were calculated. One-way analysis of variance was used to test whether
factors had an effect on basal (control) levels of cAMP, and Dunnett's
test was used to determine whether agents affected stimulated events
using Minitab statistics software package (Daniel, 1976).
RESULTS
AM secretion from keratinocytes change with time The
cellular content of AM and its accumulation in the culture medium
of human oral and skin keratinocytes (keratinocytes) was measured
after incubation periods of 1, 2, 6, and 12 h. Table I shows the
AM content in the culture medium increased throughout the
period of measurement with skin keratinocytes secreting 40% more
AM than oral keratinocytes. The rate of secretion of AM from the
cultures of oral and skin keratinocytes was 2.08 fmol per 106 cells
per h and 2.91 fmol per 106 cells per h as an average over a 12 h
period, respectively. In contrast, apart from an increase in cellular
AM levels after 1 h in both oral and skin keratinocytes (Table I),
the cellular content of AM remained unchanged, suggesting AM
was not stored but was secreted constitutively.
AM secretion from keratinocytes is regulated by various
agents Based on data of regulation of AM secretion from
cultured vascular smooth muscle and endothelial cells (Isumi et al,
1998), cells were exposed to a variety of agents to test their effects
on AM secretion after a 12 h incubation period. Table II shows
that most substances tested signi®cantly in¯uenced AM secretion
from oral and skin keratinocytes. For oral keratinocytes eight agents
increased and ®ve substances decreased AM secretion, whereas for
skin keratinocytes, nine substances increased, four substances
decreased and six had no effect on AM secretion. Cytokines IL-
1a, IL-1b, TNF-a and TNF-b all increased AM secretion
Table I. AM production from keratinocytes increased with timea
Time point Secreted AM (fmol per 10
6 cells) Intracellular AM (fmol per 106 cells) (h)
Oral keratinocytes Skin keratinocytes Oral keratinocytes Skin keratinocytes
0 7.4 6 0.05 10.1 6 1.6 0.27 6 0.01 0.31 6 0.04
1 10.2 6 0.9* 15.6 6 1.2* 0.33 6 0.05 0.37 6 0.09
2 15.3 6 1.3* 21.3 6 1.8* 0.31 6 0.03 0.35 6 0.05
6 21.9 6 1.9* 25.8 6 2.3* 0.29 6 0.03 0.34 6 0.04
12 25.4 6 2.9* 35.2 6 2.8* 0.28 6 0.05 0.38 6 0.05
aRate of intracellular and secreted AM levels from oral and skin keratinocytes. Each value represents mean 6 SEM, n = 4. *p < 0.05 compared with levels at time 0 h
(one-way ANOVA followed by a Dunnett's test).
Table II. Effects of cytokines and steroids on AM
secretiona
Substance Concentration
Oral
keratinocytes
(fmol AM per
106 cells)
Skin
keratinocytes
(fmol AM per
106 cells)
Basal ± 25.4 6 2.9 35.2 6 2.8
IL-1a 0.01 ng per ml 30.5 6 2.8* 34.6 6 3.1
IL-1b 0.1 ng per ml 31.5 6 2.9* 35.2 6 3.1
TNF-a 1 ng per ml 45.6 6 3.6* 32.8 6 3.0
TNF-b 10 ng per ml 42.9 6 4.0* 36.9 6 4.2
LPS 10 ng per ml 50.2 6 4.5* 36.8 6 4.6
TGF-b1 1 ng per ml 20.9 6 3.2* 25.3 6 3.1*
IFN-g 100 U per ml 21.3 6 3.1* 28.3 6 3.1*
Thrombin 20 U per ml 29.6 6 1.7* 56.3 6 4.1*
Hydrocortisone 10±5 mol per liter 29.8 6 2.5 39.4 6 2.1*
Aldosterone 10±5 mol per liter 28.5 6 1.1 36.2 6 1.2*
Dexamethasone 10±5 mol per liter 28.6 6 1.6 37.7 6 0.28*
Testosterone 10±5 mol per liter 29.9 6 3.0 38.2 6 2.1*
Progesterone 10±5 mol per liter 28.3 6 1.6 39.1 6 2.8*
Estradiol 10±5 mol per liter 29.9 6 2.5 38.6 6 2.9*
TPA 10±9 mol per liter 35.5 6 3.4* 51.8 6 1.5*
ET-1 10±9 mol per liter 38.8 6 3.9* 49.3 6 4.1*
Forskolin 10±6 mol per liter 19.3 6 1.5* 30.2 6 3.1*
Di-butyryl
cAMP
10±6 mol per liter 22.6 6 2.1* 32.2 6 3.5
ACTH 10±9 mol per liter 19.3 6 2.8* 22.8 6 2.5*
aHuman oral and skin keratinocytes were cultured with various substances for
12 h. Each value represents mean 6 SEM, n = 4. *p < 0.05 compared with basal
(control) levels (one-way ANOVA followed by a Dunnett's test).
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signi®cantly from oral keratinocytes but had no effect on skin
keratinocytes. The greatest increase was seen with TNF-a and
TNF-b, which almost doubled secretion over the 12 h period. As
shown in Fig 1(A), signi®cant increases in AM secretion from oral
keratinocytes were not observed until 1 ng TNF-a per ml was
used. No change in AM secretion from skin keratinocytes was seen
at any concentration. This was also re¯ected at the mRNA level as
depicted in Fig 1(B). A similar dichotomy of response between
oral and skin keratinocytes was seen with LPS: AM secretion more
than doubled from oral keratinocytes but skin keratinocytes did not
respond. Threshold stimulation of oral keratinocytes with LPS
occurred at 10 ng per ml (Fig 2A). Figure 2(B) illustrates the
effect of a maximal amount of LPS (10 ng per ml) on AM mRNA
level in both oral and skin cells.
TPA caused concentration-dependent increases in AM secretion
from both cell types (between 10±9 and 10±8 mol per liter), but at
higher concentrations, TPA did not have a stimulatory effect and
AM levels returned to basal levels (Fig 3A). Figure 3(B) shows
that 10±9 mol TPA per liter caused an increase in AM expression,
more so in skin keratinocytes than oral.
In both cell types TGF-b1 and IFN-g were potent suppressors of
AM secretion decreasing production by up to third. These effects
were concentration-dependent. Figure 4(A) illustrates the attenu-
ation of AM secretion from both oral and skin keratinocytes by
TGF-b1; threshold inhibition of production occurred at 1 ng
TGF-b1 per ml for both cell types. The effect of this concentration
of TGF-b1 on AM mRNA expression can be seen in Fig 4(B).
Thrombin stimulated AM secretion from both oral and skin
keratinocytes. Skin keratinocytes, however, were more responsive
than oral keratinocytes and secretion almost doubled compared
with only a 15% increase from oral keratinocytes (Table II). ET-1
also stimulated AM secretion signi®cantly from both oral and skin
keratinocytes (Table II) and Fig 5(A) illustrates the concentration-
dependent increase. The effects of 10±9 mol ET-1 per liter on AM
gene expression are shown in Fig 5(B).
The effect of six steroid and sex hormones on AM secretion from
keratinocytes were studied. Table II illustrates that skin keratino-
cytes responded to all steroids used and increased AM production
by about 10% when compared with control levels. There was little
difference in the ability of the hormones to stimulate AM secretion.
Figure 1 TNF-a caused signi®cant increases in AM protein and
mRNA levels from keratinocytes. Effects of increasing concentrations
of TNF-a on (A) AM levels in the culture medium of human oral (j)
or skin keratinocytes (s) after incubation for 12 h; (B) AM mRNA
expression in keratinocytes before (±) and after (+) 12 h exposure to
TNF-a (1 ng per ml); upper picture is a representative image of AM
mRNA levels; lower graph shows relative intensity of AM mRNA
expression after scanning densitometry and normalization to GAPDH
expression. Each value represents mean 6 SEM, n = 4. ***p < 0.001
compared with control (no treatment) levels (one-way ANOVA followed
by a Dunnett's test).
Figure 2. LPS caused signi®cant increases in AM protein and
mRNA levels from keratinocytes. Effects of increasing concentrations
of LPS on (A) AM levels in the culture medium of human oral (j) or
skin keratinocytes (s) after incubation for 12 h; (B) AM mRNA
expression in keratinocytes before (±) and after (+) 12 h exposure to LPS
(10 ng per ml); upper picture is a representative image of AM mRNA
levels; lower graph shows relative intensity of AM mRNA expression
after scanning densitometry and normalization to GAPDH expression.
Each value represents mean 6 SEM, n = 4. ***p < 0.001 compared
with control (no treatment) levels (one-way ANOVA followed by a
Dunnett's test).
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Thyroid hormone, T3, did not affect AM secretion (data not
shown). Oral keratinocytes appeared not to respond to steroid
hormones.
ACTH, forskolin and di-butyryl cAMP signi®cantly attenuated
AM secretion in both oral and skin keratinocytes (Table I).
Figure 6 illustrates the signi®cant concentration-dependent in-
hibitory affect of ACTH on AM production and mRNA levels.
Threshold inhibition occurred at 10±9 mol ACTH per liter for skin
keratinocytes and 10±10 mol ACTH per liter for oral keratinocytes.
At the gene level 10±8 mol ACTH per liter did attenuate
expression, particularly in skin keratinocytes.
IL-1a modulates AM production in response to TNF-a or
LPS TNF-a, IL-1a and LPS may act synergistically when added
simultaneously (Isumi et al, 1998) and the effect of these substances
in combination on AM secretion from oral keratinocytes was
studied. Each of the three substances individually increased AM
production (Fig 7), but only TNF-a and LPS in combination
signi®cantly increased secretion over levels seen with either
substance alone. This effect was additive rather than synergistic.
Interestingly, addition of IL-1a to a combination of TNF-a and
LPS prevented this additive effect and levels of AM production
were similar to TNF-a on its own. IL-1a also had an inhibitory
effect when added in combination with LPS and levels were similar
to that of IL-1a on its own.
DISCUSSION
Although skin keratinocytes have been shown previously to secrete
AM, this is the ®rst demonstration that oral keratinocytes produce
the peptide. Primary cultures of both oral and skin keratinocytes
were shown to synthesize and secrete AM constitutively. The rate
of AM secretion from both keratinocytes types was comparable
with that of rat vascular smooth muscle cells (Sugo et al, 1994a), but
about six times less than vascular endothelial cells (Isumi et al,
1998). The level of gene transcription of AM in the cultured
keratinocytes was lower than that of the rat adrenal gland and
vascular endothelial cells suggesting that keratinocytes are not a
major source of AM synthesis or secretion within the body.
In order to de®ne a physiologic role for AM in oral mucosa and
skin it is important to establish which factors affect the regulation of
AM production by oral and skin keratinocytes. Interesting
differences were found between the two cell types. The
constitutive level of secretion of AM from skin keratinocytes was
about 40% greater than from oral keratinocytes and, although the
maximal level of secretion following stimulation was similar for
Figure 3. TPA caused a signi®cant increase in AM protein and
mRNA levels from keratinocytes. Effects of increasing concentrations
of TPA on (A) AM levels in the culture medium of human oral (j) or
skin keratinocytes (s) after incubation for 12 h; (B) AM mRNA
expression in keratinocytes before (±) and after (+) 12 h exposure to
TPA (10±9 mol per liter); upper picture is a representative image of AM
mRNA levels; lower graph shows relative intensity of AM mRNA
expression after scanning densitometry and normalization to GAPDH
expression. Each value represents mean 6 SEM, n = 4. ***p < 0.001
compared with control (no treatment) levels (one-way ANOVA followed
by a Dunnett's test).
Figure 4. TGF-b1 caused signi®cant attenuation of AM protein
and mRNA levels from keratinocytes. Effects of increasing
concentrations of TGF-b1 on (A) AM levels in the culture medium of
human oral (j) or skin keratinocytes (s) after incubation for 12 h; (B)
AM mRNA expression in keratinocytes before (±) and after (+) 12 h
exposure to TGF-b1 (1 ng per ml); upper picture is a representative
image of AM mRNA levels; lower graph shows relative intensity of AM
mRNA expression after scanning densitometry and normalization to
GAPDH expression. Each value represents mean 6 SEM, n = 4. *p
< 0.05, **p < 0.01, ***p < 0.001 compared with control (no treatment)
levels (one-way ANOVA followed by a Dunnett's test).
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both cell types, the keratinocytes responded differently to a number
of the agents tested. Oral keratinocytes signi®cantly increased
output of AM in response to the pro-in¯ammatory cytokines IL-
1a, IL-1b, TNF-a, and TNF-b, whereas skin keratinocytes did
not respond. In addition, oral keratinocytes were particularly
responsive to the bacterial product, LPS, and AM production
doubled, whereas it had no effect on skin keratinocytes. In contrast,
skin keratinocytes were highly responsive to thrombin but the
effect on oral keratinocytes was much less marked. The signi®cance
of these differences in terms of the function of AM secretion by
keratinocytes in oral mucosa and skin is not known. Nonetheless
the ®nding that AM production from oral keratinocytes is
stimulated by pro-in¯ammatory cytokines and bacterial products
suggests AM may play an important part in immune defense of the
oral mucosa, particularly in response to microorganisms. This is
further suggested by our recent ®ndings that AM induces
intercellular adhesion molecule 1 (ICAM-1) and E-selectin
expression on oral keratinocytes and endothelial cells in vitro as
well as stimulating the release of the IL-1a and IL-6 (Farthing et al,
1999; Hagi-Pavli et al, in press). E-selectin together with ICAM-1
on vascular endothelium are important in mediating the migration
of neutrophils (Lawrence and Springer, 1993) as well as a speci®c
subset of leukocytes characterized by the expression of cutaneous
associated lymphocyte antigen from peripheral blood into the oral
mucosa and skin (Picker et al, 1991; Walton et al, 1997). IL-1a and
IL-6 play a pivotal part in the immune response by stimulating the
release of cytokines from a variety of cell types, including
keratinocytes and endothelial cells and by activating T cells and
Langerhans cells (Kondo, 1999; Murphy et al, 2000). AM itself may
therefore upregulate the immune response in oral mucosa,
particularly in response to bacterial products.
Combinations of cytokines have been shown to have a
synergistic or additive effect on the production of cytokines by
oral and skin keratinocytes (Li et al, 1996). The effect of a
combination of IL-1a, TNF-a, and LPS on AM release from oral
keratinocytes was examined, but only TNF-a and LPS together
resulted in a signi®cant additive increase in AM secretion. IL-1a in
combination with both LPS and TNF-a or LPS on its own had an
inhibitory effect on AM secretion. Similar observations have been
reported in studies using primary cultures of rat endothelial cells
(Isumi et al, 1998). It is not clear why IL-1 should have both a
stimulatory and inhibitory effect on AM secretion but these results
indicate the complexity of control of AM release that may occur
in vivo.
TPA elicited two effects on AM production from both oral and
skin keratinocytes: low concentrations increased AM secretion, but
Figure 5. ET-1 caused signi®cant increases in AM protein and
mRNA levels from keratinocytes. Effects of increasing concentrations
of ET-1 on (A) AM levels in the culture medium of human oral (j) or
skin keratinocytes (s) after incubation for 12 h; (B) AM mRNA
expression in keratinocytes before (±) and after (+) 12 h exposure to ET-
1 (10±9 mol per liter); upper picture is a representative image of AM
mRNA levels; lower graph shows relative intensity of AM mRNA
expression after scanning densitometry and normalization to GAPDH
expression. Each value represents mean 6 SEM, n = 4. ***p < 0.001
compared with control (no treatment) levels (one-way ANOVA followed
by a Dunnett's test).
Figure 6. ACTH caused signi®cant decreases in AM protein and
mRNA levels from keratinocytes. Effects of increasing concentrations
of ACTH on (A) AM levels in the culture medium of human oral (j)
or skin keratinocytes (s) after incubation for 12 h; (B) AM mRNA
expression in keratinocytes before (±) and after (+) 12 h exposure to
ACTH (10±8 mol per liter); upper picture is a representative image of
AM mRNA levels; lower graph shows relative intensity of AM mRNA
expression after scanning densitometry and normalization to GAPDH
expression. Each value represents mean 6 SEM, n = 4. *p < 0.05, ***p
< 0.001 compared with control (no treatment) levels (one-way ANOVA
followed by a Dunnett's test).
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higher concentrations (10±8±10±6 mol per liter) attenuated secre-
tion. This has also been observed in rat vascular cells (Ishimitsu et al,
1994; Isumi et al, 1998). TPA, when administered over a prolonged
period, inhibits protein kinase C activity (Nishizuki, 1998) and the
dual affect of TPA is thought to occur via the protein kinase C
pathway utilizing AP-1 and AP-2 regulatory sites in the 5¢ region of
the AM gene (Ishimitsu et al, 1994). The effect of TPA on AM
secretion from oral and skin keratinocytes suggests that protein
kinase C plays a part in the regulation of AM gene expression. In
contrast to this, forskolin and ACTH, agents that stimulate cAMP
production, and the cAMP analog, di-butyryl cAMP, all signi®-
cantly inhibited AM secretion from skin and oral keratinocytes.
The inhibitory effect with ACTH was also observed at the gene
transcription level. The AM gene has cAMP response element in its
5¢-upstream region and it is possible that the cAMP pathway
partially regulates AM gene activation in keratinocytes of the skin
and oral cavity.
Two cytokines were found to inhibit AM release from both oral
and skin keratinocytes: TGF-b1 and IFN-g. TGF-b1 is produced
by a variety of cells in mucosa, including keratinocytes and it is
thought to play an important part in downregulating the immune
response and by inhibiting cell proliferation (Matsumoto et al,
1990). It is also important in the induction of IgA (rather than IgG
or IgM synthesis) from B cells in mucosa (Coffman et al, 1989) and
induces the expression of aeb7 on intra-epithelial lymphocytes,
which facilitates their interaction with epithelium (Cepek et al,
1993). Inhibition of AM production by keratinocytes is thus
consistent with its immunosuppressive function. IFN-g on the
other hand is produced by activated T cells and high levels are
produced in the oral mucosa and skin in in¯ammatory mucocu-
taneous disease (Palliard et al, 1988) where it is thought that it may
be important in the induction of ICAM-1 on keratinocytes and
endothelial cells. Such ICAM-1 expression is associated with
migration of leukocytes from peripheral blood through vascular
endothelium and also into epithelium (Grif®ths and Nickoloff,
1989; Walton et al, 1998) and hence is important in facilitating the
immune response. Why IFN-g should inhibit AM production by
keratinocytes is not clear but indicates that in vivo secretion will be
modi®ed by a complex interplay between differing factors.
Thrombin was a potent stimulator of AM synthesis from skin
keratinocytes but its effects were much less marked on oral
keratinocytes. Thrombin plays a part in the upregulation of the
immune response by stimulating endothelial cells to express
adhesion molecules such as ICAM-1 and release cytokines
(Kaplanski et al, 1997). Our ®ndings suggest that it may also
upregulate the immune response particularly in the skin.
All steroid hormones tested stimulated a moderate increase in the
secretion of AM from skin keratinocytes and similar effects have
been reported on vascular cells (Sugo et al, 1994b, 1995a, >b; Imai
et al, 1995; Minamino et al, 1995). Receptors for glucocorticoids
are present in the cytoplasm and nuclei of skin keratinocytes (Serres
et al, 1996) and upon binding they dimerize and translocate to the
nucleus where they bind to glucocortocoid response elements on
glucocorticoid response genes (Barnes, 1998). The 5¢ regulatory
region of the AM gene has a glucocortocoid response element and a
study by Imai et al (1995) demonstrated speci®c effects of
glucocorticoid on AM gene transcription in endothelial cells.
Interestingly, steroid hormones had no statistical effect on oral
keratinocytes.
At present the reason for these differences in the regulation of
AM secretion from skin and oral keratinocytes are not clear.
Receptors for IL-1, TNF, and so-called Toll receptors that bind
LPS share a common intracellular pathway, which results in the
translocation of the transcription factor NF-kB from the cytoplasm
to the nucleus (see Murphy et al, 2000 for review). NF-kB is part
of a highly conserved family and plays a key part in host defense. It
is important in the induction of in¯ammatory cytokines, such as IL-
1 and TNF-a, chemokines, including IL-8 and monocyte
chemotactic protein-1, as well as the induction of adhesion
molecules ICAM-1, vascular cell adhesion molecule-1, and E-
selectin (Barnes and Karin, 1997). As IL-1, TNF, and LPS induce
AM production in oral keratinocytes, our results suggest NF-kB
may also be important in the regulation of its production; however,
skin keratinocytes also respond to IL-1, TNF, and LPS by
producing cytokines and chemokines (Kondo, 1999) and presum-
ably by NF-kB, and it is not clear why they also do not produce
AM. Presumably, there is a difference at the genetic level in the
control of AM secretion between skin and oral keratinocytes but
this is yet to be investigated.
In conclusion, this study has shown that there are interesting
differences in the regulation of AM secretion between oral and skin
keratinocytes and that oral keratinocytes are particularly responsive
to the effects of proin¯ammatory cytokines and bacterial LPS. This
raises the possibility that there are functional differences in the role
of AM between the oral mucosa and skin.
The authors wish to thank the Central Research Fund of the University of London
and The Royal Society for funding.
REFERENCES
Barnes PJ, Karin M: Nuclear factor-kB-a pivotal transcription factor in chronic
in¯ammatory diseases. N Engl J Med 336:1066±1071, 1997
Barnes PJ: Anti-in¯ammatory actions of glucocorticoids: molecular mechanisms. Clin
Sci 94:557±572, 1998
Cepek KL, Parker CM, Madara JL, Brenner MB: Integrin alpha E beta 7 mediates
adhesion of T lymphocytes to epithelial cells. J Immunol 150:3459±3464, 1993
Coffman RL, Lebman DA, Schrader B: Transforming growth factor beta speci®cally
enhances IgA production by lipopolysaccharide-stimulated murine B
lymphocytes. J Exp Med 170:1039±1044, 1989
Daniel C: Applications of Statistics to Industrial Experimentation. New York: Wiley, 1976
Eguchi S, Hirata Y, Iwasaki H, et al: Structure-activity relationship of
adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular
smooth-muscle cells. Endocrinology 135:2454±2458, 1994
Farthing PM, Hagi-Pavli E, Brown D, Kapas S: Vasoactive peptides stimulate ICAM-
Figure 7 IL-1a attenuated LPS- or TNF-a-stimulated AM
production from oral keratinocytes. Effects of coincubating TNF-a
(1 ng per ml), LPS (10 ng per ml), and IL-1a (0.01 ng per ml) for 12 h
on AM secretion from oral keratinocytes. Each value represents
mean 6 SEM, n = 4. *p < 0.05, ***p < 0.001 compared with control
levels; +++p < 0.001 compared with AM levels stimulated by TNF-a,
LPS, or IL-1a (Student's t test).
358 KAPAS ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
1 expression on endothelial cells and oral keratinocytes. J Dent Res 78:1044,
1999
Grif®ths CE, Nickoloff B: Keratinocyte adhesion molecule-1 (ICAM-1) expression
precedes dermal T lymphocyte in®ltration in allergic contact dermatitis. Am J
Pathol 20:736±739, 1989
Hagi-Pavli E, Farthing PM, Brown D, Kapas S: Induction of E-selectin on oral
keratinocytes by vasoactive peptides. J Dent Res in press
Hinson, JP, Kapas, S, Smith, DM: Adrenomedullin, a multifunctional regulatory
peptide. Endocr Rev 21:138±167, 2000
Imai T, Hirata Y, Iwashina M, et al: Hormonal regulation of rat adrenomedullin gene
in vasculature. Endocrinology 136:1544±1548, 1995
Ishimitsu T, Kojima M, Kangawa K, et al: Genomic structure of human
adrenomedullin gene. Biochem Biophys Res Commun 203:631±639, 1994
Ishizaka Y, Ishizaka Y, Tanaka M, et al: Adrenomedullin stimulates cyclic AMP
formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun
200:642±646, 1994
Isumi Y, Shoji H, Sugo S, et al: Regulation of adrenomedullin production in rat
endothelial cells. Endocrinology 139:838±846, 1998
Kapas S, Brown DW, Farthing PM, Hagi-Pavli E: Adrenomedullin has mitogenic
effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett
418:287±290, 1997
Kapas S, Hagi-Pavli E, Brown DW, et al: Direct effects of corticotrophin on oral
keratinocyte cell proliferation. Eur J Biochem 256:75±79, 1998a
Kapas S, MartõÂnez A, Cuttitta F, et al: Local production and action of adrenomedullin
in the rat adrenal zona glomerulosa. J Endocrinol 156:477±484, 1998b
Kaplanski G, Fabrigoule M, Boulay V, et al: Thrombin induces endothelial type II
activation in vitro. J Immunol 158:5435±5441, 1997
Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive
peptide isolated from human pheochromocytoma. Biochem Biophys Res
Commun 192:553±560, 1993a
Kitamura K, Sakata J, Kangawa K, et al: Cloning and characterization of cDNA
encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun
194:720±725, 1993b
Kondo S: The roles of keratinocyte-derived cytokines in the epidermis and their
possible responses to UV irradiation. J Invest Dermatol Proc 4:177±183, 1999
Lawrence MB, Springer TA: Neutrophils roll on E-selectin. J Immunol
151:6338±6347, 1993
Li J, Farthing PM, Ireland GW, Thornhill MH: IL-1a and IL-6 production by oral
and skin keratinocytes: similarities and differences in response to cytokine
treatment in vitro. J Oral Pathol Med 25:157±162, 1996
Li J, Farthing PM, Thornhill MH: Oral and skin keratinocytes are stimulated to
secrete monocyte chemoattractant protein-1 by tumour necrosis factor-a and
interferon-g. J Oral Pathol Med 29:438±444, 2000
Malcovati M, Tenchini ML: Cell density affects spreading and clustering, but not
attachment, of human keratinocytes in serum-free medium. J Cell Sci
99:387±395, 1991
MartõÂnez A, Elsasser TH, MuroCacho C, et al: Expression of adrenomedullin and its
receptor in normal and malignant human skin: a potential pluripotent role in
the integument. Endocrinology 138:5597±5604, 1997
Matsumoto K, Hashimoto K, Hashiro M, et al: Modulation of growth and
differentiation in normal human keratinocytes by transforming growth
factor-beta. J Cell Physiol 145:95±101, 1990
Minamino N, Shoji H, Sugo S, et al: Adrenocortical steroids, thyroid hormones and
retinoic acid augment the production of adrenomedullin in vascular smooth
muscle cells. Biochem Biophys Res Commun 211:686±693, 1995
Murphy JE, Robert C, Kupper TS: Interleukin-1 and cutaneous in¯ammation: a
crucial link between innate and acquired immunity. J Invest Dermatol
114:602±608, 2000
Nishizuki Y: The molecular heterogeneity of protein kinase C and its implication for
cellular regulation. Nature 334:661±665, 1998
Palliard X, de Waal Male®jt R, Yssel H, et al: Simultaneous production of IL-2, IL-4,
and IFN-gamma by activated human CD4+ and CD8+ T cell clones. J
Immunol 141:849±855, 1988
Picker LJ, Kishimoto TK, Smith CW, et al: ELAM-1 is an adhesion molecule for
skin-homing T cells. Nature 249:796±799, 1991
Rheinwald JG, Green H: Serial cultivation of strains of human epidermal
keratinocytes: the formation of keratinizing colonies from single cells. Cell
6:331±344, 1975
Serres M, Viac J, Schrutt D: Glucocorticoid receptor localisation in human epidermal
cells. Arch Dermatol Res 288:140±146, 1996
Sugo S, Minamino N, Shoji H, et al: Production and secretion of adrenomedullin
from vascular smooth muscle cells: augmented production by tumor necrosis
factor-alpha. Biochem Biophys Res Commun 203:719±726, 1994a
Sugo S, Minamino N, Kangawa K, et al: Endothelial cells actively synthesize and
secrete adrenomedullin. Biochem Biophys Res Commun 201:1160±1166, 1994b
Sugo S, Minamino N, Shoji H, et al: Interleukin-1, tumor-necrosis-factor and
lipopolysaccharide additively stimulate production of adrenomedullin in
vascular smooth- muscle cells. Biochem Biophys Res Commun 207:25±32, 1995a
Sugo S, Minamino N, Shoji H, et al: Effects of vasoactive substances and cAMP
related compounds on adrenomedullin production in cultured vascular smooth
muscle cells. FEBS Lett 369:311±314, 1995b
Walton LJ, Thornhill MH, Macey MG, Farthing PM: Cutaneous lymphocyte-
associated (CLA) and aeb7 are expressed by mononuclear cells in skin and oral
lichen planus. J Oral Pathol Med 26:402±407, 1997
Walton LJ, Thornhill MH, Farthing PM: Intraepithelial subpopulations of T
lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med
27:116±123, 1998
VOL. 117, NO. 2 AUGUST 2001 ADRENOMEDULLIN SECRETION FROM KERATINOCYTES 359
